Literature DB >> 21757662

Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Neeraj Badjatia1, Amanda Carpenter, Luis Fernandez, J Michael Schmidt, Stephan A Mayer, Jan Claassen, Kiwon Lee, E Sander Connolly, David Seres, Mitchell S V Elkind.   

Abstract

BACKGROUND AND
PURPOSE: Subarachnoid hemorrhage (SAH) is known to result in elevated systemic oxygen consumption (Vo(2)) and increases in high-sensitivity C-reactive protein (hsCRP), although the relationship among hsCRP, Vo(2), and delayed cerebral ischemia (DCI) after SAH remains unknown. We hypothesized that hsCRP is directly associated with Vo(2) and that elevated Vo(2) is a predictor of DCI after SAH.
METHODS: Prospective serial assessments of Vo(2) and hsCRP over 4 prespecified time periods during the first 14 days after bleed in consecutive SAH patients admitted to a single academic medical center for a 2-year period.
RESULTS: One hundred ten SAH patients met study criteria (mean age, 55±16 years; 62% women), with a median admission Hunt Hess grade of 3 (interquartile range, 2-4). In multivariate generalized estimating equation model of the first 14 days after bleed, Vo(2) was associated with younger age (P=0.01), male gender (P=0.01), and hsCRP levels (P=0.03). Twenty-four (22%) patients had DCI develop, with a median onset on day 7 after bleed (interquartile range, 5-11). The mean Vo(2) (291±65 mL/min versus 226±55 mL/min; P=0.003) was higher in DCI patients. In a multivariable Cox proportional hazards model, younger age (hazard ratio, 1.2 per 5 years; 95% CI, 1.1-1.3), a higher modified Fisher scale score (hazard ratio, 3.4 per 1-point increase; 95% CI, 1.7-6.9), and higher Vo(2) (HR, 1.2 per 50-mL/min increase; 95% CI, 1.1-1.3) were predictive of DCI.
CONCLUSIONS: Systemic oxygen consumption is associated with hsCRP levels in the first 14 days after SAH and is an independent predictor of DCI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21757662     DOI: 10.1161/STROKEAHA.111.614685

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

1.  Free Fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage.

Authors:  Neeraj Badjatia; David Seres; Amanda Carpenter; J Michael Schmidt; Kiwon Lee; Stephan A Mayer; Jan Claassen; E Sander Connolly; Mitchell S Elkind
Journal:  Stroke       Date:  2012-01-26       Impact factor: 7.914

2.  Current Advances in the Use of Therapeutic Hypothermia.

Authors:  Neeraj Badjatia; Christopher J White; Abbot Laptook; Markus Föedisch
Journal:  Ther Hypothermia Temp Manag       Date:  2013-09       Impact factor: 1.286

3.  Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Takashi Tagami; Kentaro Kuwamoto; Akihiro Watanabe; Kyoko Unemoto; Shoji Yokobori; Gaku Matsumoto; Yutaka Igarashi; Hiroyuki Yokota
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

4.  Heart rate variability for preclinical detection of secondary complications after subarachnoid hemorrhage.

Authors:  J Michael Schmidt; Daby Sow; Michael Crimmins; David Albers; Sachin Agarwal; Jan Claassen; E Sander Connolly; Mitchell S V Elkind; George Hripcsak; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

5.  Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Neeraj Badjatia; Aimee Monahan; Amanda Carpenter; Jacqueline Zimmerman; J Michael Schmidt; Jan Claassen; E Sander Connolly; Stephan A Mayer; Wahida Karmally; David Seres
Journal:  Neurology       Date:  2015-01-16       Impact factor: 9.910

6.  Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome.

Authors:  Jan Claassen; David Albers; J Michael Schmidt; Gian Marco De Marchis; Deborah Pugin; Christina Maria Falo; Stephan A Mayer; Serge Cremers; Sachin Agarwal; Mitchell S V Elkind; E Sander Connolly; Vanja Dukic; George Hripcsak; Neeraj Badjatia
Journal:  Ann Neurol       Date:  2014-05-16       Impact factor: 10.422

7.  IN VITRO QUANTIFICATION OF THE SIZE DISTRIBUTION OF INTRASACCULAR VOIDS LEFT AFTER ENDOVASCULAR COILING OF CEREBRAL ANEURYSMS.

Authors:  Chander Sadasivan; Jeremy Brownstein; Bhumika Patel; Ronak Dholakia; Joseph Santore; Fawaz Al-Mufti; Enrique Puig; Audrey Rakian; Kenneth D Fernandez-Prada; Mohamed S Elhammady; Hamad Farhat; David J Fiorella; Henry H Woo; Mohammad A Aziz-Sultan; Baruch B Lieber
Journal:  Cardiovasc Eng Technol       Date:  2013-03-01       Impact factor: 2.495

Review 8.  Biomarkers as outcome predictors in subarachnoid hemorrhage--a systematic review.

Authors:  Caron M Hong; Cigdem Tosun; David B Kurland; Volodymyr Gerzanich; David Schreibman; J Marc Simard
Journal:  Biomarkers       Date:  2014-02-05       Impact factor: 2.658

9.  Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome.

Authors:  Gian Marco De Marchis; Deborah Pugin; Emma Meyers; Angela Velasquez; Sureerat Suwatcharangkoon; Soojin Park; M Cristina Falo; Sachin Agarwal; Stephan Mayer; J Michael Schmidt; E Sander Connolly; Jan Claassen
Journal:  Neurology       Date:  2015-12-23       Impact factor: 9.910

10.  Serum glutamine and hospital-acquired infections after aneurysmal subarachnoid hemorrhage.

Authors:  Neeraj Badjatia; Serge Cremers; Jan Claassen; E Sander Connolly; Stephan A Mayer; Wahida Karmally; David Seres
Journal:  Neurology       Date:  2018-06-29       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.